Harrisvaccines, housed in the ISU Research Park, is helping fight avian influenza and its work has recently been recognized by the United States Department of Agriculture.
Harrisvaccines has been granted a conditional license from the USDA for the company’s avian influenza vaccine. This is the first conditional license for the avian influenza that has killed more than 48 million birds since the spring of 2015.
